Innovative Treatment Modalities for Keloids: Contact Cryotherapy
Michael H Tirgan MD
BACKGROUND
Keloids represent a therapeutic challenge due to their high recurrence rates and resistance to conventional treatment. Surgical excision, often considered a first-line treatment, is associated with recurrence rates exceeding 50% even when combined with adjuvant therapies. Similarly, intralesional corticosteroid injections, another widely used modality, provide variable results, with recurrence rates ranging from 9% to 50% and frequent complications, including hypopigmentation, atrophy, and pain. These outcomes underscore the need for innovative and more effective treatments.
CONCLUSION
This presentation will review the evidence supporting the efficacy and safety of these innovative treatment modalities, highlighting their potential to transform the current paradigm of keloid management. By leveraging the unique mechanisms and the precision of contact cryotherapy, clinicians can achieve superior outcomes, reduce recurrence rates, and improve the quality of life for patients with keloids.
The methods, results, figures and the downloadable PDF are available to subscribers.
